Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 13, 2024 2:36 PM 2 min read

Analyst Recommends Trump-Linked Phunware For Solid Results In 2H24 And 2025 - Here's Why

by Nabaparna Bhattacharya Benzinga Editor
Follow

H.C. Wainwright analyst Scott Buck reiterated the Buy rating on Phunware, Inc. (NASDAQ:PHUN), adjusted the price target to $12 from $1, following the company’s recent 1-for-50 reverse share split.

Yesterday, Phunware reported quarterly continuing operations losses of $(17.62) per share.

While revenue is likely to remain somewhat disappointing in the near term, the analyst highlights the firm’s plans for a strategic shift in sales methodology.

In terms of go-forward strategy, Phunware expects to leverage the success of its location-based platform in the hospitality, healthcare, and corporate campus verticals, Buck notes. 

Specifically, the analyst recommended investors to build a position ahead of improving operating results in 2H24 and 2025.

According to the analyst, while the path to profitability may remain somewhat unclear, the new management team now has the resources available for multiple quarters to prove out it’s selling strategy. 

Buck now models 2024 revenue of $6 million, up 25.0% from restated 2023 levels. The analyst projects a 2025 revenue of $10 million.

On the flip side, Roth MKM analyst Darren Aftahi lowered the price forecast on Phunware to $20 from $25 (split adjusted).

Aftahi writes that sales may take time to materialize. However, the analyst keeps a Buy rating, citing that the company has a renewed focus on hospitality, improving its sales efforts and leveraging partnerships as a Trojan horse, which, if proven out, could later be transferred to the healthcare vertical. 

Lastly, the company’s crypto angle could see a new revival, something that hardly gets any credit. Aftahi projects 2025 revenue of $8.5 million.

Phunware has ties to Donald Trump dating back to 2020 when the company announced that it was working on the development, launch and ongoing management of the Trump-Pence 2020 Reelection Campaign’s mobile application portfolio.

Price Action: PHUN shares are trading lower by 11.8% to $9.17 on the last check Wednesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsMoversTrading IdeasGeneralBriefsExpert Ideaswhy it's moving
PHUN Logo
PHUNPhunware Inc
$1.801.12%
Overview
PHUN Logo
PHUNPhunware Inc
$1.801.12%
Overview
Comments
Loading...